Received Mar 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
only the men b component of the vaccine was administered; only the men b component of the vaccine was administered; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Men ABCWY NVS (Penmenvy) for prophylaxis. On an unknown date, the patient received Penmenvy. On an unknown date, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: only the men b component of the vaccine was administered ) and inappropriate dose of vaccine administered (Verbatim: only the men b component of the vaccine was administered ). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 10-MAR-2026 Reporter stated that only the men b component of the vaccine was administered and they would like to know how to proceed. The batch number was not provided and a request for this information has been made.